文献速递乳腺癌放疗放疗物理与技术

早期乳腺癌保乳术后超低分割图像引导部分乳腺照射的2期试验

Phase 2 Trial of Ultrahypofractionated Image-guided Partial Breast Irradiation Following Lumpectomy with Optional Oncoplastic Reconstruction for Early-stage Breast Cancer.
PubMed 文献 · Adv Radiat Oncol · 2025-06-22

该前瞻性2期试验纳入50岁及以上、雌激素受体阳性、0至1期且肿瘤≤3 cm的保乳术后早期乳腺癌患者,采用Varian Edge放射外科系统给予30 Gy/5次的部分乳腺照射,主要终点为可行性与安全性。

要点

  • 50岁及以上ER阳性0-1期保乳术后患者接受30 Gy/5次部分乳腺照射可行。
  • 全部患者局部控制,2例同侧乳腺事件均成功挽救,肿瘤整形重建非禁忌。

核心结论

  • 在严格选择的低危早期乳腺癌患者中,5次部分乳腺照射方案取得极好的美容与肿瘤学结局。
  • 肿瘤整形重建不是部分乳腺照射的禁忌证。

研究设计与样本

  • 前瞻性2期试验,纳入50岁及以上、雌激素受体阳性、0至1期且肿瘤≤3 cm、保乳术后(可选肿瘤整形重建)的女性。
  • 患者接受Varian Edge放射外科系统30 Gy/5次部分乳腺照射,主要终点为可行性与安全性。
  • 2018至2022年共入组50例患者52个肿瘤,中位年龄76岁,79%为浸润性乳腺癌,48%接受肿瘤整形重建。

主要发现

  • 中位随访47个月,长期患者报告美容效果极好占89%、良好占11%。
  • 全部患者局部控制,出现2例同侧乳腺事件:1例乳内淋巴结失败和1例照射野外第二原发三阴性乳腺癌,均经进一步局部和全身治疗成功挽救。

关键数值与推荐

  • 处方剂量30 Gy分5次。
  • 美容效果采用经验证的乳腺癌治疗结局量表评估。

临床怎么用

  • 对严格选择的低危早期乳腺癌保乳术后患者,可考虑30 Gy/5次部分乳腺照射。
  • 肿瘤整形重建后仍可安全实施部分乳腺照射。

局限性

  • 单臂2期试验,样本量50例,中位随访47个月。
  • 原文未报告长期毒性、剂量学参数及与标准分割的对照比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: As accelerated partial breast irradiation is gaining widespread acceptance for low-risk breast cancers treated with breast conservation, its role following oncoplastic surgery remains controversial. METHODS AND MATERIALS: We performed a prospective phase 2 trial of women aged 50 and older who were estrogen receptor positive with stage 0 to 1 breast cancer measuring ≤3 cm following successful lumpectomy with optional oncoplastic reconstruction. Patients were treated on the Varian Edge radiosurgery system to a prescribed dose of 30 Gy in 5 fractions, and the primary endpoints were feasibility and safety. Patient-reported cosmesis was assessed using the Breast Cancer Treatment Outcome Scale validated instrument. RESULTS: From 2018 to 2022, 50 patients with 52 tumors with a median age of 76 were enrolled, including 79% invasive breast cancer with 48% undergoing oncoplastic reconstruction. With a median follow-up of 47 months, long-term patient-reported cosmesis was excellent in 89% of patients and good in 11% of patients. All patients were locally controlled, but there were 2 ipsilateral breast events consisting of an intramammary lymph node failure and second primary triple-negative breast cancer outside the radiation field, both successfully salvaged with further local and systemic therapy. CONCLUSIONS: In carefully selected patients with low-risk early-stage breast cancer, patients treated with a 5-fraction regimen of partial breast irradiation achieve excellent cosmetic and oncological outcomes. Oncoplastic reconstruction was not a contraindication to partial breast irradiation.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Gupta V, Wong AT, Radigan R, et al. Phase 2 Trial of Ultrahypofractionated Image-guided Partial Breast Irradiation Following Lumpectomy with Optional Oncoplastic Reconstruction for Early-stage Breast Cancer. Adv Radiat Oncol. 2025. PMID: 40808697. doi:10.1016/j.adro.2025.101817

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。